FTC and 13 States Sue to Block Covetrus’s $3.5 Billion Acquisition of MWI
The FTC and 13 state attorneys general are seeking to block Covetrus’s proposed acquisition of veterinary supplies distributor MWI, alleging it would eliminate close competition and raise costs for veterinary clinics and pet owners. The complaint says the deal would combine the two largest suppliers in veterinary clinic distribution and distribution to large corporate accounts.
12.11.2026 | Federal Trade Commission
The Federal Trade Commission, joined by attorneys general from 13 states, filed a federal lawsuit seeking a permanent injunction to stop Covetrus Inc. and its owners, Clayton, Dubilier & Rice and TPG, from acquiring MWI Veterinary Supply Inc. from its parent, Cencora Inc., for $3.5 billion. The case was filed in the U.S. District Court for the Southern District of New York. The FTC voted 2-0 to authorize the lawsuit.
The FTC alleges that the acquisition would combine the two largest suppliers in the markets for veterinary clinic distribution and distribution to large corporate accounts. Covetrus and MWI supply veterinary practices with pharmaceuticals, vaccines, clinic consumables such as gloves and syringes, surgical supplies, and related services. Their customers include independent practices and corporate groups operating hundreds of clinics across the United States.
According to the complaint, both companies operate national distribution-center networks that enable rapid delivery and offer discounts and rebates that smaller rivals cannot match. The FTC says Covetrus and MWI compete directly on price and service, and that their rivalry has intensified in recent years. For example, Covetrus allegedly responded to MWI’s aggressive pricing by cutting prices and offering rebates through its VetSuite program. The complaint also points to Vetcove, an online platform that lets veterinarians compare prices and use one distributor’s offers in negotiations with the other. The FTC characterizes the companies’ rivalry as an all-out price war.
The FTC claims that eliminating this competition would increase costs for veterinary clinics, reduce service quality, and ultimately raise prices for pet owners. It also alleges that structural barriers make it difficult for new competitors to enter the market. Specialty distributors, manufacturers, retailers, and other fringe suppliers may offer some relevant products or services, but, according to the complaint, they do not meaningfully constrain the major veterinary clinic distributors.
The agency argues that the transaction would create highly concentrated markets and is presumptively unlawful under antitrust case law and the FTC and Department of Justice’s joint merger guidelines. The state attorneys general joining the case represent Arizona, Arkansas, California, Colorado, Maine, Michigan, Minnesota, Nebraska, New York, North Carolina, Ohio, Oregon, and Texas.
